Yan, Yongcong
Lu, Yingjuan
Mao, Kai
Zhang, Mengyu
Liu, Haohan
Zhou, Qianlei
Lin, Jianhong
Zhang, Jianlong
Wang, Jie
Xiao, Zhiyu
Funding for this research was provided by:
National Natural Science Foundation of China (81572407, 81602112, 81672405)
Key project of Natural Science Foundation of Guangdong Province, China (4210016041)
Science and Technology Program of Guangdong Province, China (2015A030313096, 2016A030313184)
Natural Science Foundation of Guangzhou, China (4250016043)
Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology (Grant [2013] 163)
Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes (KLB09001)
Article History
Received: 20 February 2019
Accepted: 14 June 2019
First Online: 18 July 2019
Compliance with ethical standards
:
: Yongcong Yan, Yingjuan Lu, Kai Mao, Mengyu Zhang, Haohan Liu, Qianlei Zhou, Jianhong Lin, Jianlong Zhang, Jie Wang and Zhiyu Xiao have no conflicts of interest for this study.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. This study was approved by the institutional ethics committee of Sun Yat-Sen Memorial Hospital and informed consent was obtained from all patients.